6-52236935-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_052872.4(IL17F):āc.488A>Gā(p.Gln163Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,612,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_052872.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL17F | NM_052872.4 | c.488A>G | p.Gln163Arg | missense_variant | 3/3 | ENST00000336123.5 | NP_443104.1 | |
IL17F | XM_011514276.1 | c.488A>G | p.Gln163Arg | missense_variant | 4/4 | XP_011512578.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL17F | ENST00000336123.5 | c.488A>G | p.Gln163Arg | missense_variant | 3/3 | 1 | NM_052872.4 | ENSP00000337432 | P1 | |
IL17F | ENST00000478427.1 | n.672A>G | non_coding_transcript_exon_variant | 2/2 | 1 | |||||
IL17F | ENST00000699946.1 | c.488A>G | p.Gln163Arg | missense_variant | 4/4 | ENSP00000514702 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250916Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135606
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1460412Hom.: 0 Cov.: 29 AF XY: 0.0000303 AC XY: 22AN XY: 726654
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74486
ClinVar
Submissions by phenotype
Candidiasis, familial, 6 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 30, 2022 | This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 163 of the IL17F protein (p.Gln163Arg). This variant is present in population databases (rs571639953, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with IL17F-related conditions. ClinVar contains an entry for this variant (Variation ID: 1503585). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at